|
It was nice to see that BIOC hit the $17.1 million in revenue.
It was even better to see that BIOC beat analysts' estimates by +33% (posting +$0.04 vs. the estimate of $0.03) for the quarter. $1.4 million in cash flow from operations it quite good during Q2. And business (backlog) is increasing. Good time to buy BIOC at a discount (below $4/sh). Sentiment : Strong Buy Rating :
 (No ratings) |
42/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|